CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,000 | -26.3% | 7,529 | +45.5% | 0.00% | – |
| Q2 2023 | $19,000 | +137.5% | 5,173 | +104.0% | 0.00% | – |
| Q1 2023 | $8,000 | +60.0% | 2,536 | -15.5% | 0.00% | – |
| Q4 2022 | $5,000 | -44.4% | 3,000 | -52.8% | 0.00% | – |
| Q3 2022 | $9,000 | -18.2% | 6,356 | +30.9% | 0.00% | – |
| Q2 2022 | $11,000 | +10.0% | 4,856 | +60.1% | 0.00% | – |
| Q1 2022 | $10,000 | -81.8% | 3,034 | -76.9% | 0.00% | – |
| Q4 2021 | $55,000 | -25.7% | 13,108 | +43.4% | 0.00% | – |
| Q3 2021 | $74,000 | +27.6% | 9,140 | +16.8% | 0.00% | – |
| Q2 2021 | $58,000 | -4.9% | 7,823 | +12.0% | 0.00% | – |
| Q1 2021 | $61,000 | +32.6% | 6,983 | +18.9% | 0.00% | – |
| Q4 2020 | $46,000 | +84.0% | 5,872 | +85.9% | 0.00% | – |
| Q3 2020 | $25,000 | -60.9% | 3,159 | -51.2% | 0.00% | – |
| Q2 2020 | $64,000 | -5.9% | 6,479 | -26.8% | 0.00% | – |
| Q1 2020 | $68,000 | +209.1% | 8,857 | +51.9% | 0.00% | – |
| Q4 2019 | $22,000 | -8.3% | 5,830 | +26.7% | 0.00% | – |
| Q3 2019 | $24,000 | +14.3% | 4,600 | +47.3% | 0.00% | – |
| Q2 2019 | $21,000 | -40.0% | 3,122 | -32.1% | 0.00% | – |
| Q1 2019 | $35,000 | -5.4% | 4,600 | -0.2% | 0.00% | – |
| Q4 2018 | $37,000 | -54.9% | 4,610 | -27.9% | 0.00% | – |
| Q3 2018 | $82,000 | +51.9% | 6,395 | +33.1% | 0.00% | – |
| Q2 2018 | $54,000 | +74.2% | 4,803 | +9.2% | 0.00% | – |
| Q1 2018 | $31,000 | -18.4% | 4,400 | -25.1% | 0.00% | – |
| Q4 2017 | $38,000 | +123.5% | 5,874 | +109.4% | 0.00% | – |
| Q3 2017 | $17,000 | +112.5% | 2,805 | +55.8% | 0.00% | – |
| Q2 2017 | $8,000 | -57.9% | 1,800 | -58.1% | 0.00% | – |
| Q1 2017 | $19,000 | +18.8% | 4,300 | +48.3% | 0.00% | – |
| Q4 2016 | $16,000 | -27.3% | 2,900 | -17.1% | 0.00% | – |
| Q3 2016 | $22,000 | +450.0% | 3,500 | +337.5% | 0.00% | – |
| Q2 2016 | $4,000 | +33.3% | 800 | 0.0% | 0.00% | – |
| Q1 2016 | $3,000 | -25.0% | 800 | 0.0% | 0.00% | – |
| Q4 2015 | $4,000 | -20.0% | 800 | 0.0% | 0.00% | – |
| Q3 2015 | $5,000 | 0.0% | 800 | 0.0% | 0.00% | – |
| Q2 2015 | $5,000 | -54.5% | 800 | 0.0% | 0.00% | – |
| Q1 2015 | $11,000 | +37.5% | 800 | 0.0% | 0.00% | – |
| Q4 2014 | $8,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |